HIV rapid testing in drug treatment

Comparison across treatment modalities

Robert P. Schwartz, Maxine L. Stitzer, Daniel J. Feaster, Philip (Todd) Korthuis, Anika A H Alvanzo, Theresa M. Winhusen, Lillian Donnard, Ned Snead, Lisa R. Metsch

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Despite high rates of risky behavior among patients, many drug abuse treatment programs do not provide on-site HIV testing. This secondary analysis examined differences in outcome by program modality from a multi-site trial in which 1281 HIV-negative patients in three methadone programs, seven non-methadone outpatient programs, and three residential programs were randomly assigned to: (1) off-site referral for HIV risk reduction counseling and testing; or on-site rapid testing (2) with or (3) without risk reduction counseling. The parent study using generalized estimating equations with site as a cluster variable found significantly higher rates of HIV testing and feedback of results by 1. month post-enrollment for the combined on-site conditions compared to the offsite condition [RR=4.52, 97.5% CI (3.57, 5.72)]. Utilizing the same statistical approach, we found neither significant treatment modality nor significant treatment modality by testing condition interaction effects either for receipt of HIV test results at 1. month or for sexual or drug use HIV-risk behaviors at 6-month follow-up. On-site HIV testing is effective across treatment modalities for achieving high rates of testing and results feedback. All programs should be encouraged to adopt or expand this service.

Original languageEnglish (US)
Pages (from-to)369-374
Number of pages6
JournalJournal of Substance Abuse Treatment
Volume44
Issue number4
DOIs
StatePublished - Apr 2013

Fingerprint

HIV
Pharmaceutical Preparations
Risk Reduction Behavior
Therapeutics
Counseling
Methadone
Risk-Taking
Substance-Related Disorders
Outpatients
Referral and Consultation

Keywords

  • Drug treatment programs
  • HIV rapid testing
  • HIV risk behavior

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Clinical Psychology
  • Phychiatric Mental Health
  • Medicine (miscellaneous)

Cite this

Schwartz, R. P., Stitzer, M. L., Feaster, D. J., Korthuis, P. T., Alvanzo, A. A. H., Winhusen, T. M., ... Metsch, L. R. (2013). HIV rapid testing in drug treatment: Comparison across treatment modalities. Journal of Substance Abuse Treatment, 44(4), 369-374. https://doi.org/10.1016/j.jsat.2012.08.219

HIV rapid testing in drug treatment : Comparison across treatment modalities. / Schwartz, Robert P.; Stitzer, Maxine L.; Feaster, Daniel J.; Korthuis, Philip (Todd); Alvanzo, Anika A H; Winhusen, Theresa M.; Donnard, Lillian; Snead, Ned; Metsch, Lisa R.

In: Journal of Substance Abuse Treatment, Vol. 44, No. 4, 04.2013, p. 369-374.

Research output: Contribution to journalArticle

Schwartz, RP, Stitzer, ML, Feaster, DJ, Korthuis, PT, Alvanzo, AAH, Winhusen, TM, Donnard, L, Snead, N & Metsch, LR 2013, 'HIV rapid testing in drug treatment: Comparison across treatment modalities', Journal of Substance Abuse Treatment, vol. 44, no. 4, pp. 369-374. https://doi.org/10.1016/j.jsat.2012.08.219
Schwartz, Robert P. ; Stitzer, Maxine L. ; Feaster, Daniel J. ; Korthuis, Philip (Todd) ; Alvanzo, Anika A H ; Winhusen, Theresa M. ; Donnard, Lillian ; Snead, Ned ; Metsch, Lisa R. / HIV rapid testing in drug treatment : Comparison across treatment modalities. In: Journal of Substance Abuse Treatment. 2013 ; Vol. 44, No. 4. pp. 369-374.
@article{90508a86fdac435083704ff953fc943e,
title = "HIV rapid testing in drug treatment: Comparison across treatment modalities",
abstract = "Despite high rates of risky behavior among patients, many drug abuse treatment programs do not provide on-site HIV testing. This secondary analysis examined differences in outcome by program modality from a multi-site trial in which 1281 HIV-negative patients in three methadone programs, seven non-methadone outpatient programs, and three residential programs were randomly assigned to: (1) off-site referral for HIV risk reduction counseling and testing; or on-site rapid testing (2) with or (3) without risk reduction counseling. The parent study using generalized estimating equations with site as a cluster variable found significantly higher rates of HIV testing and feedback of results by 1. month post-enrollment for the combined on-site conditions compared to the offsite condition [RR=4.52, 97.5{\%} CI (3.57, 5.72)]. Utilizing the same statistical approach, we found neither significant treatment modality nor significant treatment modality by testing condition interaction effects either for receipt of HIV test results at 1. month or for sexual or drug use HIV-risk behaviors at 6-month follow-up. On-site HIV testing is effective across treatment modalities for achieving high rates of testing and results feedback. All programs should be encouraged to adopt or expand this service.",
keywords = "Drug treatment programs, HIV rapid testing, HIV risk behavior",
author = "Schwartz, {Robert P.} and Stitzer, {Maxine L.} and Feaster, {Daniel J.} and Korthuis, {Philip (Todd)} and Alvanzo, {Anika A H} and Winhusen, {Theresa M.} and Lillian Donnard and Ned Snead and Metsch, {Lisa R.}",
year = "2013",
month = "4",
doi = "10.1016/j.jsat.2012.08.219",
language = "English (US)",
volume = "44",
pages = "369--374",
journal = "Journal of Substance Abuse Treatment",
issn = "0740-5472",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - HIV rapid testing in drug treatment

T2 - Comparison across treatment modalities

AU - Schwartz, Robert P.

AU - Stitzer, Maxine L.

AU - Feaster, Daniel J.

AU - Korthuis, Philip (Todd)

AU - Alvanzo, Anika A H

AU - Winhusen, Theresa M.

AU - Donnard, Lillian

AU - Snead, Ned

AU - Metsch, Lisa R.

PY - 2013/4

Y1 - 2013/4

N2 - Despite high rates of risky behavior among patients, many drug abuse treatment programs do not provide on-site HIV testing. This secondary analysis examined differences in outcome by program modality from a multi-site trial in which 1281 HIV-negative patients in three methadone programs, seven non-methadone outpatient programs, and three residential programs were randomly assigned to: (1) off-site referral for HIV risk reduction counseling and testing; or on-site rapid testing (2) with or (3) without risk reduction counseling. The parent study using generalized estimating equations with site as a cluster variable found significantly higher rates of HIV testing and feedback of results by 1. month post-enrollment for the combined on-site conditions compared to the offsite condition [RR=4.52, 97.5% CI (3.57, 5.72)]. Utilizing the same statistical approach, we found neither significant treatment modality nor significant treatment modality by testing condition interaction effects either for receipt of HIV test results at 1. month or for sexual or drug use HIV-risk behaviors at 6-month follow-up. On-site HIV testing is effective across treatment modalities for achieving high rates of testing and results feedback. All programs should be encouraged to adopt or expand this service.

AB - Despite high rates of risky behavior among patients, many drug abuse treatment programs do not provide on-site HIV testing. This secondary analysis examined differences in outcome by program modality from a multi-site trial in which 1281 HIV-negative patients in three methadone programs, seven non-methadone outpatient programs, and three residential programs were randomly assigned to: (1) off-site referral for HIV risk reduction counseling and testing; or on-site rapid testing (2) with or (3) without risk reduction counseling. The parent study using generalized estimating equations with site as a cluster variable found significantly higher rates of HIV testing and feedback of results by 1. month post-enrollment for the combined on-site conditions compared to the offsite condition [RR=4.52, 97.5% CI (3.57, 5.72)]. Utilizing the same statistical approach, we found neither significant treatment modality nor significant treatment modality by testing condition interaction effects either for receipt of HIV test results at 1. month or for sexual or drug use HIV-risk behaviors at 6-month follow-up. On-site HIV testing is effective across treatment modalities for achieving high rates of testing and results feedback. All programs should be encouraged to adopt or expand this service.

KW - Drug treatment programs

KW - HIV rapid testing

KW - HIV risk behavior

UR - http://www.scopus.com/inward/record.url?scp=84873749866&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873749866&partnerID=8YFLogxK

U2 - 10.1016/j.jsat.2012.08.219

DO - 10.1016/j.jsat.2012.08.219

M3 - Article

VL - 44

SP - 369

EP - 374

JO - Journal of Substance Abuse Treatment

JF - Journal of Substance Abuse Treatment

SN - 0740-5472

IS - 4

ER -